Royal Bank Of Canada Alpha Tau Medical Ltd. Transaction History
Royal Bank Of Canada
- $471 Billion
- Q3 2024
A detailed history of Royal Bank Of Canada transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Royal Bank Of Canada holds 1,500 shares of DRTS stock, worth $4,620. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,500
Previous 1,500
-0.0%
Holding current value
$4,620
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DRTS
# of Institutions
29Shares Held
1.36MCall Options Held
0Put Options Held
0-
Levin Capital Strategies, L.P. New York, NY307KShares$946,5610.07% of portfolio
-
Hoyle Cohen, LLC269KShares$828,7910.05% of portfolio
-
High Tower Advisors, LLC Chicago, IL231KShares$710,5680.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$204,2840.01% of portfolio
-
Satovsky Asset Management LLC53.6KShares$165,1060.03% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $213M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...